SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 19.80% growth in the revenue at Rs. 6991.40 millions for the quarter ended March 2023 as compared to Rs. 5835.80 millions during the year-ago period.Profit saw a slight increase of 7.19%to Rs. 886.70  millions from Rs. 827.20 millions.Operating Profit saw a handsome growth to 1647.40 millions from 1234.50 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 6991.40 5835.80 19.80 28841.60 21898.80 31.70 28841.60 21898.80 31.70
Other Income 33.00 18.50 78.38 86.50 386.10 -77.60 86.50 386.10 -77.60
PBIDT 1647.40 1234.50 33.45 6733.40 5475.20 22.98 6733.40 5475.20 22.98
Interest 122.60 15.80 675.95 343.10 49.50 593.13 343.10 49.50 593.13
PBDT 1524.80 1218.70 25.12 6390.30 5425.70 17.78 6390.30 5425.70 17.78
Depreciation 305.60 217.90 40.25 1119.90 712.80 57.11 1119.90 712.80 57.11
PBT 1219.20 1000.80 21.82 5270.40 4712.90 11.83 5270.40 4712.90 11.83
TAX 332.50 173.60 91.53 1381.50 1102.90 25.26 1381.50 1102.90 25.26
Deferred Tax 109.00 -136.40 -179.91 548.00 -122.10 -548.81 548.00 -122.10 -548.81
PAT 886.70 827.20 7.19 3888.90 3610.00 7.73 3888.90 3610.00 7.73
Equity 154.80 154.60 0.13 154.80 154.60 0.13 154.80 154.60 0.13
PBIDTM(%) 23.56 21.15 11.39 23.35 25.00 -6.62 23.35 25.00 -6.62

JB Chem & Pharma Share Price

1989.15 -9.50 (-0.48%)
15-Apr-2026 14:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1691.40
Dr. Reddys Lab 1217.55
Cipla 1225.00
Zydus Lifesciences 932.45
Lupin 2340.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×